Country: United States
Language: English
Source: NLM (National Library of Medicine)
azelaic acid (UNII: F2VW3D43YT) (azelaic acid - UNII:F2VW3D43YT)
Physicians Total Care, Inc.
azelaic acid
azelaic acid 0.2 g in 1 g
CUTANEOUS
PRESCRIPTION DRUG
AZELEX® Cream is indicated for the topical treatment of mild-to-moderate inflammatory acne vulgaris. AZELEX® Cream is contraindicated in individuals who have shown hypersensitivity to any of its components.
AZELEX® Cream is supplied in a closed orifice tube with a white, spiked screwcap in the following sizes: 30 g - NDC 54868-4442-0 Note: Protect from freezing. Store product on its side. Store between 15° - 30° C (59° - 86° F). Rx Only. Distributed by: Irvine, California 92612, U.S.A. ©2004 Allergan, Inc. Made in Italy 8466X Distributed under license. ® Mark of Allergan, Inc. Revised May 2004 70896US15P Additional barcode labeling by: Physicians Total Care, Inc. Tulsa, Oklahoma 74146
New Drug Application
AZELEX - AZELAIC ACID CREAM PHYSICIANS TOTAL CARE, INC. ---------- AZELEX® (AZELAIC ACID CREAM) 20% FOR DERMATOLOGIC USE ONLY NOT FOR OPHTHALMIC USE DESCRIPTION AZELEX (azelaic acid cream) 20% contains azelaic acid, a naturally occurring saturated dicarboxylic acid. Structural Formula: HOOC-(CH ) -COOH Chemical Name: 1,7-heptanedicarboxylic acid Empirical Formula: C H O Molecular Weight: 188.22 ACTIVE INGREDIENT: Each gram of AZELEX contains azelaic acid......... 0.2 gm (20% w/w). INACTIVE INGREDIENTS: cetearyl octanoate; glycerin; glyceryl stearate and cetearyl alcohol and cetyl palmitate and cocoglycerides; PEG-5 glyceryl stearate; propylene glycol; and purified water. Benzoic acid is present as a preservative. CLINICAL PHARMACOLOGY The exact mechanism of action of azelaic acid is not known. The following _in vitro_ data are available, but their clinical significance is unknown. Azelaic acid has been shown to possess antimicrobial activity against _Propionibacterium acnes and Staphylococcus epidermidis._ The antimicrobial action may be attributable to inhibition of microbial cellular protein synthesis. A normalization of keratinization leading to an anticomedonal effect of azelaic acid may also contribute to its clinical activity. Electron microscopic and immunohistochemical evaluation of skin biopsies from human subjects treated with AZELEX Cream demonstrated a reduction in the thickness of the stratum corneum, a reduction in number and size of keratohyalin granules, and a reduction in the amount and distribution of filaggrin (a protein component of keratohyalin) in epidermal layers. This is suggestive of the ability to decrease microcomedo formation. PHARMACOKINETICS: Following a single application of AZELEX Cream to human skin _in vitro_, azelaic acid penetrates into the stratum corneum (approximately 3 to 5% of the applied dose) and other viable skin layers (up to 10% of the dose is found in the epidermis and dermis). Negligible cutaneous metabolism occurs after topical application. Approximately 4% of the Read the complete document